0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Osimertinib Mesylate Tablets Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-20P18263
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Osimertinib Mesylate Tablets Market Research Report 2024
BUY CHAPTERS

Global Osimertinib Mesylate Tablets Market Research Report 2026

Code: QYRE-Auto-20P18263
Report
2026-02-13
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Osimertinib Mesylate Tablets Market

The global Osimertinib Mesylate Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Osimertinib Mesylate Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Osimertinib mesylate tablets are a medication used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations.These tablets are designed to inhibit the activity of the mutated EGFR, thereby slowing down or stopping cancer cell growth,which are often prescribed for patients with advanced or metastatic NSCLC who have developed resistance to other EGFR-targeted therapies.
The North American market for Osimertinib Mesylate Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Osimertinib Mesylate Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Osimertinib Mesylate Tablets include AstraZeneca, Zydus, Drug International, Beacon, General Pharmaceuticals, Pharmacil, Wanbang Biopharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Osimertinib Mesylate Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Osimertinib Mesylate Tablets. The Osimertinib Mesylate Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Osimertinib Mesylate Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Osimertinib Mesylate Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Osimertinib Mesylate Tablets Market Report

Report Metric Details
Report Name Osimertinib Mesylate Tablets Market
Segment by Type
  • Original Drug
  • Generic Drug
by Application
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Zydus, Drug International, Beacon, General Pharmaceuticals, Pharmacil, Wanbang Biopharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Osimertinib Mesylate Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Osimertinib Mesylate Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Osimertinib Mesylate Tablets Market report?

Ans: The main players in the Osimertinib Mesylate Tablets Market are AstraZeneca, Zydus, Drug International, Beacon, General Pharmaceuticals, Pharmacil, Wanbang Biopharmaceuticals

What are the Application segmentation covered in the Osimertinib Mesylate Tablets Market report?

Ans: The Applications covered in the Osimertinib Mesylate Tablets Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Osimertinib Mesylate Tablets Market report?

Ans: The Types covered in the Osimertinib Mesylate Tablets Market report are Original Drug, Generic Drug

1 Osimertinib Mesylate Tablets Market Overview
1.1 Product Definition
1.2 Osimertinib Mesylate Tablets by Type
1.2.1 Global Osimertinib Mesylate Tablets Market Value by Type: 2025 vs 2032
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Osimertinib Mesylate Tablets by Application
1.3.1 Global Osimertinib Mesylate Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Osimertinib Mesylate Tablets Market Size Estimates and Forecasts
1.4.1 Global Osimertinib Mesylate Tablets Revenue 2021–2032
1.4.2 Global Osimertinib Mesylate Tablets Sales 2021–2032
1.4.3 Global Osimertinib Mesylate Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Osimertinib Mesylate Tablets Market Competition by Manufacturers
2.1 Global Osimertinib Mesylate Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Osimertinib Mesylate Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Osimertinib Mesylate Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Osimertinib Mesylate Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Osimertinib Mesylate Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Osimertinib Mesylate Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Osimertinib Mesylate Tablets, Date of Entry into the Industry
2.8 Global Osimertinib Mesylate Tablets Market Competitive Situation and Trends
2.8.1 Global Osimertinib Mesylate Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Osimertinib Mesylate Tablets Players Market Share by Revenue
2.8.3 Global Osimertinib Mesylate Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Osimertinib Mesylate Tablets Market Scenario by Region
3.1 Global Osimertinib Mesylate Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Osimertinib Mesylate Tablets Sales by Region: 2021–2032
3.2.1 Global Osimertinib Mesylate Tablets Sales by Region: 2021–2026
3.2.2 Global Osimertinib Mesylate Tablets Sales by Region: 2027–2032
3.3 Global Osimertinib Mesylate Tablets Revenue by Region: 2021–2032
3.3.1 Global Osimertinib Mesylate Tablets Revenue by Region: 2021–2026
3.3.2 Global Osimertinib Mesylate Tablets Revenue by Region: 2027–2032
3.4 North America Osimertinib Mesylate Tablets Market Facts & Figures by Country
3.4.1 North America Osimertinib Mesylate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Osimertinib Mesylate Tablets Sales by Country (2021–2032)
3.4.3 North America Osimertinib Mesylate Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Osimertinib Mesylate Tablets Market Facts & Figures by Country
3.5.1 Europe Osimertinib Mesylate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Osimertinib Mesylate Tablets Sales by Country (2021–2032)
3.5.3 Europe Osimertinib Mesylate Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Osimertinib Mesylate Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Osimertinib Mesylate Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Osimertinib Mesylate Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Osimertinib Mesylate Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Osimertinib Mesylate Tablets Market Facts & Figures by Country
3.7.1 Latin America Osimertinib Mesylate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Osimertinib Mesylate Tablets Sales by Country (2021–2032)
3.7.3 Latin America Osimertinib Mesylate Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Osimertinib Mesylate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Osimertinib Mesylate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Osimertinib Mesylate Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Osimertinib Mesylate Tablets Sales by Type (2021–2032)
4.1.1 Global Osimertinib Mesylate Tablets Sales by Type (2021–2026)
4.1.2 Global Osimertinib Mesylate Tablets Sales by Type (2027–2032)
4.1.3 Global Osimertinib Mesylate Tablets Sales Market Share by Type (2021–2032)
4.2 Global Osimertinib Mesylate Tablets Revenue by Type (2021–2032)
4.2.1 Global Osimertinib Mesylate Tablets Revenue by Type (2021–2026)
4.2.2 Global Osimertinib Mesylate Tablets Revenue by Type (2027–2032)
4.2.3 Global Osimertinib Mesylate Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Osimertinib Mesylate Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Osimertinib Mesylate Tablets Sales by Application (2021–2032)
5.1.1 Global Osimertinib Mesylate Tablets Sales by Application (2021–2026)
5.1.2 Global Osimertinib Mesylate Tablets Sales by Application (2027–2032)
5.1.3 Global Osimertinib Mesylate Tablets Sales Market Share by Application (2021–2032)
5.2 Global Osimertinib Mesylate Tablets Revenue by Application (2021–2032)
5.2.1 Global Osimertinib Mesylate Tablets Revenue by Application (2021–2026)
5.2.2 Global Osimertinib Mesylate Tablets Revenue by Application (2027–2032)
5.2.3 Global Osimertinib Mesylate Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Osimertinib Mesylate Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Osimertinib Mesylate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AstraZeneca Osimertinib Mesylate Tablets Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Zydus
6.2.1 Zydus Company Information
6.2.2 Zydus Description and Business Overview
6.2.3 Zydus Osimertinib Mesylate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Zydus Osimertinib Mesylate Tablets Product Portfolio
6.2.5 Zydus Recent Developments/Updates
6.3 Drug International
6.3.1 Drug International Company Information
6.3.2 Drug International Description and Business Overview
6.3.3 Drug International Osimertinib Mesylate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Drug International Osimertinib Mesylate Tablets Product Portfolio
6.3.5 Drug International Recent Developments/Updates
6.4 Beacon
6.4.1 Beacon Company Information
6.4.2 Beacon Description and Business Overview
6.4.3 Beacon Osimertinib Mesylate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Beacon Osimertinib Mesylate Tablets Product Portfolio
6.4.5 Beacon Recent Developments/Updates
6.5 General Pharmaceuticals
6.5.1 General Pharmaceuticals Company Information
6.5.2 General Pharmaceuticals Description and Business Overview
6.5.3 General Pharmaceuticals Osimertinib Mesylate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 General Pharmaceuticals Osimertinib Mesylate Tablets Product Portfolio
6.5.5 General Pharmaceuticals Recent Developments/Updates
6.6 Pharmacil
6.6.1 Pharmacil Company Information
6.6.2 Pharmacil Description and Business Overview
6.6.3 Pharmacil Osimertinib Mesylate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Pharmacil Osimertinib Mesylate Tablets Product Portfolio
6.6.5 Pharmacil Recent Developments/Updates
6.7 Wanbang Biopharmaceuticals
6.7.1 Wanbang Biopharmaceuticals Company Information
6.7.2 Wanbang Biopharmaceuticals Description and Business Overview
6.7.3 Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Product Portfolio
6.7.5 Wanbang Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Osimertinib Mesylate Tablets Industry Chain Analysis
7.2 Osimertinib Mesylate Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Osimertinib Mesylate Tablets Production Mode & Process Analysis
7.4 Osimertinib Mesylate Tablets Sales and Marketing
7.4.1 Osimertinib Mesylate Tablets Sales Channels
7.4.2 Osimertinib Mesylate Tablets Distributors
7.5 Osimertinib Mesylate Tablets Customer Analysis
8 Osimertinib Mesylate Tablets Market Dynamics
8.1 Osimertinib Mesylate Tablets Industry Trends
8.2 Osimertinib Mesylate Tablets Market Drivers
8.3 Osimertinib Mesylate Tablets Market Challenges
8.4 Osimertinib Mesylate Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Osimertinib Mesylate Tablets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Osimertinib Mesylate Tablets Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Osimertinib Mesylate Tablets Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Osimertinib Mesylate Tablets Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Osimertinib Mesylate Tablets Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Osimertinib Mesylate Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Osimertinib Mesylate Tablets Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Osimertinib Mesylate Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Osimertinib Mesylate Tablets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Osimertinib Mesylate Tablets, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Osimertinib Mesylate Tablets, Product Types and Applications
 Table 12. Global Key Manufacturers of Osimertinib Mesylate Tablets, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Osimertinib Mesylate Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Osimertinib Mesylate Tablets Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Osimertinib Mesylate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Osimertinib Mesylate Tablets Sales by Region (K Units), 2021–2026
 Table 18. Global Osimertinib Mesylate Tablets Sales Market Share by Region (2021–2026)
 Table 19. Global Osimertinib Mesylate Tablets Sales by Region (K Units), 2027–2032
 Table 20. Global Osimertinib Mesylate Tablets Sales Market Share by Region (2027–2032)
 Table 21. Global Osimertinib Mesylate Tablets Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Osimertinib Mesylate Tablets Revenue Market Share by Region (2021–2026)
 Table 23. Global Osimertinib Mesylate Tablets Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Osimertinib Mesylate Tablets Revenue Market Share by Region (2027–2032)
 Table 25. North America Osimertinib Mesylate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Osimertinib Mesylate Tablets Sales by Country (K Units), 2021–2026
 Table 27. North America Osimertinib Mesylate Tablets Sales by Country (K Units), 2027–2032
 Table 28. North America Osimertinib Mesylate Tablets Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Osimertinib Mesylate Tablets Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Osimertinib Mesylate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Osimertinib Mesylate Tablets Sales by Country (K Units), 2021–2026
 Table 32. Europe Osimertinib Mesylate Tablets Sales by Country (K Units), 2027–2032
 Table 33. Europe Osimertinib Mesylate Tablets Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Osimertinib Mesylate Tablets Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Osimertinib Mesylate Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Osimertinib Mesylate Tablets Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Osimertinib Mesylate Tablets Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Osimertinib Mesylate Tablets Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Osimertinib Mesylate Tablets Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Osimertinib Mesylate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Osimertinib Mesylate Tablets Sales by Country (K Units), 2021–2026
 Table 42. Latin America Osimertinib Mesylate Tablets Sales by Country (K Units), 2027–2032
 Table 43. Latin America Osimertinib Mesylate Tablets Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Osimertinib Mesylate Tablets Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Osimertinib Mesylate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Osimertinib Mesylate Tablets Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Osimertinib Mesylate Tablets Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Osimertinib Mesylate Tablets Sales (K Units) by Type (2021–2026)
 Table 51. Global Osimertinib Mesylate Tablets Sales (K Units) by Type (2027–2032)
 Table 52. Global Osimertinib Mesylate Tablets Sales Market Share by Type (2021–2026)
 Table 53. Global Osimertinib Mesylate Tablets Sales Market Share by Type (2027–2032)
 Table 54. Global Osimertinib Mesylate Tablets Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Osimertinib Mesylate Tablets Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Osimertinib Mesylate Tablets Revenue Market Share by Type (2021–2026)
 Table 57. Global Osimertinib Mesylate Tablets Revenue Market Share by Type (2027–2032)
 Table 58. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Osimertinib Mesylate Tablets Sales (K Units) by Application (2021–2026)
 Table 61. Global Osimertinib Mesylate Tablets Sales (K Units) by Application (2027–2032)
 Table 62. Global Osimertinib Mesylate Tablets Sales Market Share by Application (2021–2026)
 Table 63. Global Osimertinib Mesylate Tablets Sales Market Share by Application (2027–2032)
 Table 64. Global Osimertinib Mesylate Tablets Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Osimertinib Mesylate Tablets Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Osimertinib Mesylate Tablets Revenue Market Share by Application (2021–2026)
 Table 67. Global Osimertinib Mesylate Tablets Revenue Market Share by Application (2027–2032)
 Table 68. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Application (2027–2032)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. AstraZeneca Osimertinib Mesylate Tablets Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Zydus Company Information
 Table 76. Zydus Description and Business Overview
 Table 77. Zydus Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Zydus Osimertinib Mesylate Tablets Product
 Table 79. Zydus Recent Developments/Updates
 Table 80. Drug International Company Information
 Table 81. Drug International Description and Business Overview
 Table 82. Drug International Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Drug International Osimertinib Mesylate Tablets Product
 Table 84. Drug International Recent Developments/Updates
 Table 85. Beacon Company Information
 Table 86. Beacon Description and Business Overview
 Table 87. Beacon Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Beacon Osimertinib Mesylate Tablets Product
 Table 89. Beacon Recent Developments/Updates
 Table 90. General Pharmaceuticals Company Information
 Table 91. General Pharmaceuticals Description and Business Overview
 Table 92. General Pharmaceuticals Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. General Pharmaceuticals Osimertinib Mesylate Tablets Product
 Table 94. General Pharmaceuticals Recent Developments/Updates
 Table 95. Pharmacil Company Information
 Table 96. Pharmacil Description and Business Overview
 Table 97. Pharmacil Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Pharmacil Osimertinib Mesylate Tablets Product
 Table 99. Pharmacil Recent Developments/Updates
 Table 100. Wanbang Biopharmaceuticals Company Information
 Table 101. Wanbang Biopharmaceuticals Description and Business Overview
 Table 102. Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Product
 Table 104. Wanbang Biopharmaceuticals Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Osimertinib Mesylate Tablets Distributors List
 Table 108. Osimertinib Mesylate Tablets Customers List
 Table 109. Osimertinib Mesylate Tablets Market Trends
 Table 110. Osimertinib Mesylate Tablets Market Drivers
 Table 111. Osimertinib Mesylate Tablets Market Challenges
 Table 112. Osimertinib Mesylate Tablets Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Osimertinib Mesylate Tablets
 Figure 2. Global Osimertinib Mesylate Tablets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Osimertinib Mesylate Tablets Market Share by Type: 2025 & 2032
 Figure 4. Original Drug Product Picture
 Figure 5. Generic Drug Product Picture
 Figure 6. Global Osimertinib Mesylate Tablets Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Osimertinib Mesylate Tablets Market Share by Application: 2025 & 2032
 Figure 8. Hospital and Clinic
 Figure 9. Retail Pharmacies
 Figure 10. Other
 Figure 11. Global Osimertinib Mesylate Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Osimertinib Mesylate Tablets Market Size (US$ Million), 2021–2032
 Figure 13. Global Osimertinib Mesylate Tablets Sales (K Units), 2021–2032
 Figure 14. Global Osimertinib Mesylate Tablets Average Price (US$/Unit), 2021–2032
 Figure 15. Osimertinib Mesylate Tablets Report Years Considered
 Figure 16. Osimertinib Mesylate Tablets Sales Share by Manufacturers in 2025
 Figure 17. Global Osimertinib Mesylate Tablets Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Osimertinib Mesylate Tablets Players: Market Share by Revenue in Osimertinib Mesylate Tablets in 2025
 Figure 19. Osimertinib Mesylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Osimertinib Mesylate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Osimertinib Mesylate Tablets Sales Market Share by Country (2021–2032)
 Figure 22. North America Osimertinib Mesylate Tablets Revenue Market Share by Country (2021–2032)
 Figure 23. United States Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Osimertinib Mesylate Tablets Sales Market Share by Country (2021–2032)
 Figure 26. Europe Osimertinib Mesylate Tablets Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Osimertinib Mesylate Tablets Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Osimertinib Mesylate Tablets Revenue Market Share by Region (2021–2032)
 Figure 34. China Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Osimertinib Mesylate Tablets Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Osimertinib Mesylate Tablets Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Osimertinib Mesylate Tablets Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Osimertinib Mesylate Tablets Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Osimertinib Mesylate Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Osimertinib Mesylate Tablets by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Osimertinib Mesylate Tablets by Type (2021–2032)
 Figure 54. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Osimertinib Mesylate Tablets by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Osimertinib Mesylate Tablets by Application (2021–2032)
 Figure 57. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Application (2021–2032)
 Figure 58. Osimertinib Mesylate Tablets Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India